Published in Biochem J on September 01, 1965
Distribution and diffusion of solutes in articular cartilage. Biophys J (1970) 2.99
The effect of chondroitin sulphate-protein on the formation of collagen fibrils in vitro. Biochem J (1968) 1.79
Acid mucopolysaccharide patterns in aging human cartilage. J Clin Invest (1966) 1.68
Action of degradative enzymes on the light fraction of bovine septa protein polysaccharide. Biochem J (1967) 1.47
Production of arteriosclerosis by homocysteinemia. Am J Pathol (1970) 1.31
The effect of acid mucopolysaccharides and acid mucopolysaccharide-proteins on fibril formation from collagen solutions. Biochem J (1968) 1.28
Physiopathologic aspects of scleral stress-strain. Trans Am Ophthalmol Soc (1969) 1.20
Nature of the interaction of chondroitin 4-sulphate and chondroitin sulphate-proteoglycan with collagen. Biochem J (1971) 1.15
Swelling studies of bovine corneal stroma without bounding membranes. J Physiol (1980) 1.06
The synthesis of sulphated mucopolysaccharide in mouse liver following carbon tetrachloride injury. I. Autoradiographic studies. Br J Exp Pathol (1969) 1.00
Partial characterization of protocollagen from embryonic cartilage. Biochem J (1967) 0.96
Interactions between glycosaminoglycans and proteins, with particular reference to a new technique for isolating serum glycoproteins. Biochem J (1967) 0.90
Content and synthesis of glycosaminoglycans in the developing lung. J Clin Invest (1975) 0.90
Interaction of cartilage proteoglycans with collagen-substituted agarose gels. Biochem J (1975) 0.88
The relationship of hyaluronate and collagen in the bovine vitreous body. J Anat (1967) 0.87
Acid mucopolysaccharides of chick-embryo cartilage in osteolathyrism. Biochem J (1966) 0.86
The solubilization of collagen and protein-polysaccharides from the developing cartilage of lathyritic chicks. Biochem J (1969) 0.86
Lanthanum staining of developing chick cartilage and reaggregating cartilage cells. J Cell Biol (1970) 0.85
Studies on the incorporation of (U-14C)glucose and (35S)sulphate into the acid glycosaminoglycans of neonatal rat skin. Biochem J (1970) 0.83
Small angle x-ray diffraction studies of mucopolysaccharides in collagen. Biophys J (1978) 0.83
Influence of biochemical composition on endplate cartilage tensile properties in the human lumbar spine. J Orthop Res (2013) 0.83
Metachromasia and alcian blue staining of the intervertebral disc of the cat. J Anat (1968) 0.81
Polyelectrolyte-coated gold nanorods and their interactions with type I collagen. Biomaterials (2009) 0.80
The interaction of insoluble collagen and sulphated polysaccharides. Biochem J (1967) 0.79
Changes in the chemical composition of ear cartilage matrix after administration of various steroid hormones. Studies in New Zealand albino rabbits. Am J Pathol (1971) 0.75
Histochemical and ultrastructural studies in fibrodysplasia ossificans progressiva (myositis ossificans progressiva). Am J Pathol (1977) 0.75
Characterization of Collagen Type I and II Blended Hydrogels for Articular Cartilage Tissue Engineering. Biomacromolecules (2016) 0.75
Heparinization of a biomimetic bone matrix: integration of heparin during matrix synthesis versus adsorptive post surface modification. J Mater Sci Mater Med (2013) 0.75
The chemistry of connective tissues. 1. The state of combination of chondroitin sulphate in cartilage. Biochem J (1948) 3.61
THE CHARGE PROFILE OF THE TROPOCOLLAGEN MACROMOLECULE AND THE PACKING ARRANGEMENT IN NATIVE-TYPE COLLAGEN FIBRILS. Proc Natl Acad Sci U S A (1960) 3.03
Sodium chondroitin sulfate-protein complexes of cartilage. I. Molecular weight and shape. Arch Biochem Biophys (1958) 2.64
Binding of mucopolysaccharides and dyes by collagen. J Biol Chem (1951) 1.93
The formation of fibrils from collagen solutions. 3. Effect of chondroitin sulphate and some other naturally occurring polyanions on the rate of formation. Biochem J (1960) 1.91
The molecular weight of sodium chondroitin sulfate by light scattering. Arch Biochem Biophys (1956) 1.90
The structure and function of hyaluronate. Biochem Soc Symp (1961) 1.70
A structural function of mucopolysaccharide in connective tissue. Biochem J (1960) 1.35
The role of polysaccharides in corneal swelling. Exp Eye Res (1961) 1.34
Conditions of formation of euglobulin-like precipitates from serum proteins and chondroitin sulfate. J Clin Invest (1955) 1.28
Interaction of human serum beta-lipoglobulin with polyanions. J Biol Chem (1957) 1.20
The formation of fibrils from collagen solutions. IV. Effect of mucopolysaccharides and nucleic acids: an electron microscope study. J Biophys Biochem Cytol (1961) 1.17
The role of non-collagen components in the mechanical behaviour of tendon fibres. Biochim Biophys Acta (1963) 1.15
Studies on fractionated heparin. Arch Biochem Biophys (1961) 1.14
THE FORMATION OF CHONDROMUCOPROTEIN-FIBRINOGEN AND CHONDROMUCOPROTEIN-BETA-LIPOPROTEIN COMPLEXES. Biochem J (1963) 1.14
The nature of collagen-chondroitin sulphate linkages in tendon. Biochem J (1954) 1.10
METABOLISM OF ACID MUCOPOLYSACCHARIDES. Biophys J (1964) 1.05
Particle interaction in solutions derived from ox vitreous humor. J Biophys Biochem Cytol (1955) 1.03
FRICTIONAL EFFECTS IN THE MIGRATION OF MIXTURES OF HYALURONIC ACID AND SERUM ALBUMIN. Biochim Biophys Acta (1963) 1.03
Interactions of hyaluronic acid with serum albumin. Biochim Biophys Acta (1961) 0.97
[The nature of functional disorders of connective tissue]. Verh Dtsch Ges Inn Med (1959) 0.96
THE FORMATION, COMPOSITION AND FIBRINOLYTIC POTENTIAL OF CHONDROMUCOPROTEIN-FIBRINOGEN AND CHONDROMUCOPROTEIN-LIPOPROTEIN COMPLEXES IN HUMAN EUGLOBULIN FRACTIONS. Clin Sci (1964) 0.95
Sodium condroitin sulfate-protein complexes of cartilage. III. Preparation from shark. Biochim Biophys Acta (1962) 0.95
Birefingent fibres of hyaluronic acid. Biochim Biophys Acta (1955) 0.95
An electrophoretic investigation of interactions between bovine plasma albumin and charged dextran derivatives. Biochem J (1961) 0.94
THE EFFECTS OF PAPAIN, VITAMIN A, AND CORTISONE ON CARTILAGE MATRIX IN VIVO. Biophys J (1964) 0.91
HYDRATION OF CONNECTIVE TISSUE AND TENDON ELASTICITY. Biochim Biophys Acta (1964) 0.86
Some factors affecting the interaction of hyaluronic acid with bovine-plasma albumin. Biochim Biophys Acta (1963) 0.86
The complex binding between protein and mucopolysaccharide in connective tissue. Acta Physiol Pharmacol Neerl (1956) 0.82
[Studies on collagen fibers. II. Comparative chemical, polarization and electron microscopic studies on collagen fibers with chondroitin sulfate as the basic substance]. Acta Histochem (1961) 0.81
Isolation of neutral heteropolysaccharide containing mucoprotein from bovine Achilles tendon with the aid of collagenmucoproteinase. Biochem J (1960) 0.81
[The mucopolysaccharides of the cornea: distribution, role, changes in normal and pathological corneas]. Arch Ophtalmol Rev Gen Ophtalmol (1963) 0.80
[Studies of collagen fibers. Part 1. On the submicroscopic structure of collagen fibers prepared in vitro and the stabilizing role of acid mucopolysaccharides]. Acta Histochem (1960) 0.80
A possible precursor of immunoglobulin light chains. Nat New Biol (1972) 11.03
Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev (1997) 6.88
Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature (1987) 6.45
Translation of globin messenger RNA in a heterologous cell-free system. Nature (1971) 6.29
HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell (1989) 6.11
Translation of RNA from encephalomyocarditis virus in a mammalian cell-free system. Nature (1970) 5.89
The gene for polypeptide IX of adenovirus type 2 and its unspliced messenger RNA. Cell (1980) 5.80
The cell-cycle regulated proliferating cell nuclear antigen is required for SV40 DNA replication in vitro. Nature (1987) 4.43
Multiple functional domains in the adenovirus E1A gene. Cell (1987) 4.22
Interactions between double-stranded RNA regulators and the protein kinase DAI. Mol Cell Biol (1992) 4.16
Identification of separate domains in the adenovirus E1A gene for immortalization activity and the activation of virus early genes. Mol Cell Biol (1986) 3.52
Structure of genes for virus-associated RNAI and RNAII of adenovirus type 2. Proc Natl Acad Sci U S A (1980) 3.45
Identity of the proliferating cell nuclear antigen and cyclin. Nature (1984) 3.44
A mechanism for the control of protein synthesis by adenovirus VA RNAI. Cell (1986) 3.43
Control of adenovirus early gene expression: a class of immediate early products. Cell (1980) 3.41
Identification of the gene and mRNA for the adenovirus terminal protein precursor. Cell (1981) 3.39
DNA replication and the early to late transition in adenovirus infection. Cell (1980) 3.17
A new species of virus-coded low molecular weight RNA from cells infected with adenovirus type 2. Cell (1976) 3.00
Interaction between VA RNA and the lupus antigen La: formation of a ribonucleoprotein particle in vitro. Proc Natl Acad Sci U S A (1982) 2.83
Regulation of a protein synthesis initiation factor by adenovirus virus-associated RNA. Nature (1985) 2.80
Proteins and messenger RNAs of the transforming region of wild-type and mutant adenoviruses. J Mol Biol (1980) 2.73
Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature (1983) 2.71
Two RNA-binding motifs in the double-stranded RNA-activated protein kinase, DAI. Genes Dev (1992) 2.70
Translational control by adenovirus: lack of virus-associated RNAI during adenovirus infection results in phosphorylation of initiation factor eIF-2 and inhibition of protein synthesis. Proc Natl Acad Sci U S A (1985) 2.53
Purification and activation of the double-stranded RNA-dependent eIF-2 kinase DAI. Mol Cell Biol (1989) 2.48
Proteins binding to duplexed RNA: one motif, multiple functions. Trends Biochem Sci (2000) 2.47
Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2alpha kinases PKR and GCN2. Mol Cell Biol (1998) 2.39
Different functional domains of the adenovirus E1A gene are involved in regulation of host cell cycle products. Mol Cell Biol (1987) 2.38
Regulation of proliferating cell nuclear antigen during the cell cycle. J Biol Chem (1989) 2.33
Genes for VA-RNA in adenovirus 2. Cell (1975) 2.32
Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation. Genes Dev (1990) 2.30
Binding of adenovirus VA RNA to mRNA: a possible role in splicing? Nature (1980) 2.28
Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR. RNA (2000) 2.25
Purification of an adenovirus-coded DNA polymerase that is required for initiation of DNA replication. Cell (1982) 2.22
Molecular and cellular effects of heat-shock and related treatments of mammalian tissue-culture cells. Cold Spring Harb Symp Quant Biol (1982) 2.18
Double-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo. Proc Natl Acad Sci U S A (1995) 2.17
Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro. Science (1976) 2.17
Transcriptional but not translational regulation of HIV-1 by the tat gene product. Nature (1988) 2.15
Lytic and transforming functions of individual products of the adenovirus E1A gene. J Virol (1986) 2.14
HIV-1 Tat overcomes inefficient transcriptional elongation in vitro. J Mol Biol (1993) 2.12
Synthesis of a structural adenovirus polypeptide in the absence of viral DNA replication. Virology (1978) 2.09
Characterization of the double-stranded RNA implicated in the inhibition of protein synthesis in cells infected with a mutant adenovirus defective for VA RNA. Virology (1988) 2.06
Adenovirus type 2 early proteins: assignment of the early region 1A proteins synthesized in vivo and in vitro to specific mRNAs. Virology (1981) 2.04
La antigen recognizes and binds to the 3'-oligouridylate tail of a small RNA. Mol Cell Biol (1984) 1.97
Interaction of adenovirus VA RNAl with the protein kinase DAI: nonequivalence of binding and function. Cell (1990) 1.90
Structural requirements for double-stranded RNA binding, dimerization, and activation of the human eIF-2 alpha kinase DAI in Saccharomyces cerevisiae. Mol Cell Biol (1995) 1.84
Binding of double-stranded RNA to protein kinase PKR is required for dimerization and promotes critical autophosphorylation events in the activation loop. J Biol Chem (2001) 1.82
Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase. Proc Natl Acad Sci U S A (1990) 1.81
Translation of two messenger RNAs from lens in a cell free system from Krebs II ascites cells. Nat New Biol (1972) 1.80
Acid mucopolysaccharide patterns in aging human cartilage. J Clin Invest (1966) 1.68
Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br Med J (Clin Res Ed) (1984) 1.68
Modification of protein synthesis initiation factors and the shut-off of host protein synthesis in adenovirus-infected cells. Virology (1989) 1.66
Further studies on the translation of globin mRNA and encephalomyocarditis virus RNA in a cell-free system from Krebs II ascites cells. Biochim Biophys Acta (1972) 1.66
Functional characterization of the RNA-binding domain and motif of the double-stranded RNA-dependent protein kinase DAI (PKR). J Mol Biol (1995) 1.64
Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences. J Biol Chem (2001) 1.63
The physical locations of structural genes in adenovirus DNA. Virology (1977) 1.63
The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR. J Biol Chem (1997) 1.63
Effects of mutations in stem and loop regions on the structure and function of adenovirus VA RNAI. EMBO J (1988) 1.58
Comparative biochemistry of keratosulfates. J Biol Chem (1965) 1.57
Double-stranded RNA as an inhibitor of protein synthesis and as a substrate for a nuclease in extracts of Krebs II ascites cells. Proc Natl Acad Sci U S A (1973) 1.56
The low molecular weight of RNAs of adenovirus 2-infected cells. J Mol Biol (1978) 1.54
Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med (1984) 1.54
Arrangement of messenger RNAs and protein coding sequences in the major late transcription unit of adenovirus 2. J Mol Biol (1980) 1.53
Cellular protein and RNA antigens in autoimmune disease. Mol Biol Med (1984) 1.52
Translation of messenger RNA for immunoglobulin light chains in a cell-free system from Krebs II ascites cells. FEBS Lett (1972) 1.49
Activities of adenovirus virus-associated RNAs: purification and characterization of RNA binding proteins. Proc Natl Acad Sci U S A (1998) 1.48
Organization and expression of the left third of the genome of adenovirus. Cold Spring Harb Symp Quant Biol (1980) 1.48
The adenovirus E1B 19-kilodalton protein stimulates gene expression by increasing DNA levels. Mol Cell Biol (1989) 1.46
Two functionally distinct RNA-binding motifs in the regulatory domain of the protein kinase DAI. Mol Cell Biol (1995) 1.46
The regulation of the protein kinase PKR by RNA. Biochimie (1996) 1.45
Hemoglobin messenger ribonucleic acid translation in cell-free systems from rat and mouse liver and Landschutz ascites cells. Biochemistry (1972) 1.44
Removal of double-stranded contaminants from RNA transcripts: synthesis of adenovirus VA RNAI from a T7 vector. Nucleic Acids Res (1990) 1.44
Comparative biochemistry of chondroitin sulphate-proteins of cartilage and notochord. Biochem J (1971) 1.43
Tat-responsive region RNA of human immunodeficiency virus type 1 stimulates protein synthesis in vivo and in vitro: relationship between structure and function. Proc Natl Acad Sci U S A (1992) 1.41
Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis. J Exp Med (1986) 1.40
Autophosphorylation sites participate in the activation of the double-stranded-RNA-activated protein kinase PKR. Mol Cell Biol (1996) 1.40
Alterations of transcription and translation in HeLa cells exposed to amino acid analogs. Mol Cell Biol (1984) 1.34
The gene and messenger RNA for adenovirus polypeptide IX. Cell (1977) 1.34
Trans-activation of the human immunodeficiency virus long terminal repeat sequences, expressed in an adenovirus vector, by the adenovirus E1A 13S protein. Proc Natl Acad Sci U S A (1988) 1.34
Termination sequence requirements vary among genes transcribed by RNA polymerase III. J Mol Biol (1999) 1.33
Nuclear factor 90 is a substrate and regulator of the eukaryotic initiation factor 2 kinase double-stranded RNA-activated protein kinase. J Biol Chem (2001) 1.31
Transactivation of host and viral genes by the adenovirus E1B 19K tumor antigen. Oncogene (1987) 1.30
Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR. Oncogene (2000) 1.30
Response of individual adenovirus promoters to the products of the E1A gene. Oncogene (1987) 1.30
Functional mRNA can be generated by RNA polymerase III. Mol Cell Biol (1995) 1.29
The effect of acid mucopolysaccharides and acid mucopolysaccharide-proteins on fibril formation from collagen solutions. Biochem J (1968) 1.28
Organization of the double-stranded RNA-activated protein kinase DAI and virus-associated VA RNAI in adenovirus-2-infected HeLa cells. J Cell Sci (1993) 1.28
Translation of an uncapped mRNA involves scanning. J Biol Chem (1997) 1.27
Structure, function, and evolution of adenovirus-associated RNA: a phylogenetic approach. J Virol (1996) 1.25
Functional characterization of and cooperation between the double-stranded RNA-binding motifs of the protein kinase PKR. J Biol Chem (2000) 1.21
New ways of initiating translation in eukaryotes. Mol Cell Biol (2001) 1.20
Comparative analysis of the structure and function of adenovirus virus-associated RNAs. J Virol (1993) 1.19
Premature termination and processing of human immunodeficiency virus type 1-promoted transcripts. J Virol (1992) 1.17
Activation of the double-stranded-RNA-activated protein kinase and induction of vascular cell adhesion molecule-1 by poly (I).poly (C) in endothelial cells. Eur J Biochem (1995) 1.16
Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53. Proc Natl Acad Sci U S A (1996) 1.15
Autoreactive epitope defined as the anticodon region of alanine transfer RNA. Science (1987) 1.14
The adenovirus E1A transforming protein activates the proliferating cell nuclear antigen promoter via an activating transcription factor site. J Virol (1991) 1.14
Hepatitis C virus envelope protein E2 does not inhibit PKR by simple competition with autophosphorylation sites in the RNA-binding domain. J Virol (2001) 1.13
The rate of polypeptide chain elongation in a cell-free system from Krebs II ascites cells. Biochim Biophys Acta (1974) 1.13